Chemical Structure : Navitoclax
CAS No.: 923564-51-6
Catalog No.: PC-42277Not For Human Use, Lab Use Only.
Navitoclax (ABT-263) is a potent, orally bioavailable Bcl-2 family inhibitor with Ki of <1 nM for Bcl-2, Bcl-xL, and Bcl-w.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
50 mg | $128 | In stock | |
100 mg | $218 | In stock | |
250 mg | $378 | In stock | |
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Navitoclax (ABT-263) is a potent, orally bioavailable Bcl-2 family inhibitor with Ki of <1 nM for Bcl-2, Bcl-xL, and Bcl-w.
Navitoclax (ABT-263) binds more weakly to Mcl-1 and A1 (Ki>350 nM).
Navitoclax (ABT-263) disrupts Bcl-2/Bcl-xL interactions with pro-death proteins (e.g., Bim), induces apoptosis, shows cellular activity against a panel of human tumor cell lines (EC50<1 uM).
Navitoclax (ABT-263) induces complete tumor regressions in xenograft models of NSCLA and ALL.
M.Wt | 974.6127 | |
Formula | C47H55ClF3N5O6S3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Benzamide, 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]- |
1. Tse C, et al. Cancer Res. 2008 May 1;68(9):3421-8.
2. Shoemaker AR, et al. Clin Cancer Res. 2008 Jun 1;14(11):3268-77.
3. Ackler S, et al. Mol Cancer Ther. 2008 Oct;7(10):3265-74.
4. Shah OJ, et al. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12634-9.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright